Maximizing survival and minimizing toxicity

2011/01/31 by Bruce Brockstein, Bruce E. Brockstein, Everett E. Vokes · 2 citations
Medicine · #Head and Neck Cancer Studies #Head and Neck Surgical Oncology #Lung Cancer Treatments and Mutations

paper · doi:10.1038/nrclinonc.2010.226

crossref issued 2011/01/31 · crossref published 2011/01/31 · crossref published-online 2011/01/31 · openalex publication_date 2011/01/31 · crossref created 2011/01/31 · crossref published-print 2011/02/01 · openalex created_date 2016/06/24 · crossref deposited 2022/07/30 · crossref indexed 2026/03/12 · openalex updated_date 2026/07/29

Citations

• Prognostic Significance of p16 INK4A and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III Trial
• Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

Cited by

• Considerations in surgical versus non-surgical management of HPV positive oropharyngeal cancer
• HPV-positive oropharyngeal cancer [wikipedia]